TipRanks
AlzeCure Pharma AB (DE:AC6)
FRANKFURT:AC6
Germany Market
AC6
AlzeCure Pharma AB
RESEARCH TOOLSreports

AlzeCure Pharma AB (AC6) Ratios

3 Followers

AlzeCure Pharma AB Ratios

DE:AC6's free cash flow for Q1 2026 was kr0.00. For the 2026 fiscal year, DE:AC6's free cash flow was decreased by kr and operating cash flow was kr0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 4.11 2.33 4.15 3.84 2.66
Quick Ratio
 4.11 2.33 4.15 3.84 2.66
Cash Ratio
 0.47 2.14 3.82 3.54 2.47
Solvency Ratio
 1.03 -1.78 -4.24 -4.46 -5.36
Operating Cash Flow Ratio
 -1.42 -1.47 -4.26 0.37 -9.65
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
kr 87.91Mkr 28.84Mkr 25.96Mkr 23.38Mkr 17.15M
Leverage Ratios
Debt-to-Assets Ratio
 0.02 0.09 0.00 0.00 0.00
Debt-to-Equity Ratio
 0.02 0.16 0.00 0.00 0.00
Debt-to-Capital Ratio
 0.02 0.13 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
 0.00 0.07 0.00 0.00 0.00
Financial Leverage Ratio
 1.34 1.79 1.32 1.35 1.17
Debt Service Coverage Ratio
 104.82 -176.27 0.00 0.00 -13.87K
Interest Coverage Ratio
 99.33 -180.85 0.00 0.00 -14.11K
Debt to Market Cap
 0.00 0.01 0.00 0.00 0.00
Interest Debt Per Share
 0.02 0.05 0.00 0.00 <0.01
Net Debt to EBITDA
 -0.46 0.94 0.88 0.77 0.46
Profitability Margins
Gross Profit Margin
99.06%0.00%0.00%0.00%0.00%
EBIT Margin
24.60%0.00%0.00%0.00%0.00%
EBITDA Margin
25.85%0.00%0.00%0.00%0.00%
Operating Profit Margin
24.49%0.00%0.00%0.00%0.00%
Pretax Profit Margin
31.55%0.00%0.00%0.00%0.00%
Net Profit Margin
31.56%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
31.55%0.00%0.00%0.00%0.00%
Net Income Per EBT
100.03%99.96%100.00%100.00%99.64%
EBT Per EBIT
128.81%96.56%96.65%97.14%99.64%
Return on Assets (ROA)
25.10%-80.71%-102.32%-116.14%-79.11%
Return on Equity (ROE)
65.99%-144.75%-134.56%-156.33%-92.65%
Return on Capital Employed (ROCE)
25.52%-139.15%-139.22%-160.94%-93.32%
Return on Invested Capital (ROIC)
25.52%-139.15%-139.22%-160.94%-92.98%
Return on Tangible Assets
25.11%-80.73%-102.37%-116.20%-79.13%
Earnings Yield
2.77%-23.71%-40.00%-20.48%-30.12%
Efficiency Ratios
Receivables Turnover
 0.92 0.00 0.00 0.00 0.00
Payables Turnover
 0.20 0.30 0.11 0.18 0.12
Inventory Turnover
 0.00 0.00 0.00 0.00 -295.64
Fixed Asset Turnover
 27.93 0.00 0.00 0.00 0.00
Asset Turnover
 0.80 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
 1.95 0.00 0.00 0.00 0.00
Cash Conversion Cycle
 -1.43K -1.20K -3.34K -2.06K -3.10K
Days of Sales Outstanding
 395.19 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 -1.23
Days of Payables Outstanding
 1.82K 1.20K 3.34K 2.06K 3.10K
Operating Cycle
 395.19 0.00 0.00 0.00 -1.23
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.30 -0.34 -0.46 0.05 -2.09
Free Cash Flow Per Share
 -0.30 -0.34 -0.46 0.05 -2.09
CapEx Per Share
 0.00 0.00 <0.01 0.00 0.00
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 -283.25 0.00 0.00
Capital Expenditure Coverage Ratio
 0.00 0.00 -283.25 0.00 0.00
Operating Cash Flow Coverage Ratio
 -20.42 -6.76 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
 -0.42 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-3.88%-17.21%-40.02%1.68%-53.71%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 53.85 -4.26 -2.50 -4.88 -3.32
Price-to-Sales (P/S) Ratio
 10.85 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 12.13 6.11 3.36 7.63 3.08
Price-to-Free Cash Flow (P/FCF) Ratio
 -25.74 -5.81 -2.50 59.37 -1.86
Price-to-Operating Cash Flow Ratio
 -27.04 -5.81 -2.51 59.37 -1.86
Price-to-Earnings Growth (PEG) Ratio
 0.83 -1.96 0.11 0.10 0.08
Price-to-Fair Value
 12.13 6.11 3.36 7.63 3.08
Enterprise Value Multiple
 41.50 -3.24 -1.59 -4.02 -2.88
Enterprise Value
 1.04B 155.78M 56.59M 152.40M 160.44M
EV to EBITDA
 41.50 -3.24 -1.59 -4.02 -2.88
EV to Sales
 10.73 0.00 0.00 0.00 0.00
EV to Free Cash Flow
 -25.46 -4.50 -1.61 49.85 -1.61
EV to Operating Cash Flow
 -25.46 -4.50 -1.61 49.85 -1.61
Tangible Book Value Per Share
 0.66 0.33 0.34 0.38 1.27
Shareholders’ Equity Per Share
 0.66 0.33 0.34 0.38 1.27
Tax and Other Ratios
Effective Tax Rate
 0.00 >-0.01 0.00 0.00 <0.01
Revenue Per Share
 0.71 0.00 0.00 0.00 0.00
Net Income Per Share
 0.22 -0.47 -0.46 -0.60 -1.17
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.28 0.97 0.98 0.97 1.00
Research & Development to Revenue
 0.61 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.13 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.69 0.73 1.00 -0.08 1.77
Currency in SEK